Tegafur–uracil is a safe alternative for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle.
| Autor: | Cubero, Daniel I.G., Cruz, Felipe Melo, Santi, Patrícia, Silva, Ismael Dale C.G., Giglio, Auro del |
|---|---|
| Zdroj: | Therapeutic Advances in Medical Oncology; Jul2012, Vol. 4 Issue 4, p167-172, 6p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|